newsfilter
← Latest News
PR Newswire·

Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives ...